Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
By Brendan Pierson and Natalie Grover (Reuters) - The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according...
Pfizer Inc. CEO Albert Bourla tested positive for COVID-19. He tweeted Monday that he received four shots of the COVID-19 vaccine the company developed with BioNTech SE , is...
By Natalie Grover and Danilo Masoni LONDON (Reuters) -Shares in GSK, Sanofi (EPA:SASY) and Haleon fell sharply on Thursday, following declines earlier this week, amid growing...
Pfizer CEO Albert Bourla Tests Positive For COVID-19Authored by Zachary Stieber via The Epoch Times,Pfizer’s CEO has tested positive for COVID-19, he announced on Aug. 15.“I...
5:30 a.m. Pacific Time BASEL, Switzerland and NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S.
Pfizer Board Member Predicts Monkeypox Will Become A 'Public Health Failure'Authored by Jack Phillips via The Epoch Times (emphasis ours),Pfizer board member Dr. Scott Gottlieb...
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Sell | Buy | Strong Buy |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Buy | Strong Buy |
| Summary | Neutral | Strong Sell | Strong Sell | Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 9.75 | 11.75 | 8.60 | +1.51 | +18.32% | 124.44M | London | |||
| 148.00 | 150.00 | 147.90 | +0.40 | +0.27% | 11.54M | London | |||
| 55.40 | 58.84 | 54.52 | -2.14 | -3.72% | 9.00M | London | |||
| 2.40 | 2.40 | 2.40 | 0.00 | 0.00% | 2.39M | London | |||
| 133.10 | 135.15 | 132.90 | -1.75 | -1.30% | 2.82M | London | |||
| 17.00 | 17.00 | 16.00 | +1.2500 | +7.94% | 5.57M | London | |||
| 262.00 | 262.00 | 262.00 | -6.50 | -2.42% | 7.72K | London | |||
| 7.50 | 7.50 | 7.50 | -0.30 | -3.87% | 1.22M | London | |||
| 286.00 | 286.00 | 286.00 | 0.00 | 0.00% | 0.00 | London | |||
| 118.62 | 119.16 | 117.44 | +1.52 | +1.30% | 7.97M | London | |||
| 31.50 | 32.80 | 32.80 | -2.00 | -5.97% | 2.77M | London | |||
| 157.25 | 159.00 | 156.40 | +0.15 | +0.10% | 7.06M | London | |||
| 888.00 | 899.20 | 875.20 | -6.00 | -0.67% | 2.29M | London | |||
| 2.88 | 2.88 | 2.88 | 0.00 | 0.00% | 36.63K | London | |||
| 76.00 | 77.40 | 75.95 | -1.25 | -1.62% | 1.00M | London |